Authors


Kathleen Ward, MPA

Latest:

Diabetes Care Improvement in Pharmacist- Versus Nurse-Supported Patient-Centered Medical Homes

In this longitudinal comparative effectiveness study of different chronic disease self-management support approaches within 1 system, both pharmacist- and nurse-led patient-centered medical home approaches improved diabetes care.


Mohsen Shabahang, MD, PhD

Latest:

Predictive Factors of Discharge Navigation Lag Time

Examination of factors associated with discharge lag time and how this metric plays an important role in managing hospital throughput.


J. Matthew Austin, PhD

Latest:

Ensuring the Integrity and Transparency of Public Reports: How a Possible Oversight Model Could Benefit Healthcare

To address the lack of standards in public reports of provider performance, the authors outline a model to ensure the integrity and transparency of reports.


Newswise

Latest:

Understanding the Connections Between Race and Bariatric Surgery

Study Finds African Americans Less Likely to See Obesity as Harmful to Quality of Life


Cristina M. Almeida, MD, MPH

Latest:

Cervical Cancer Screening Overuse and Underuse: Patient and Physician Factors

Cervical cancer screening underuse and overuse occur commonly in clinical practice and identifiable patient and physician factors can be targeted for quality improvement.






Holly A. Rodin, PhD

Latest:

Plan Designs That Encourage the Use of Generic Drugs Over Brand-Name Drugs: An Analysis of a Free Generic Benefit

Small increases and decreases in pharmacy copayments have little influence on patients’ switching to generic drugs or on improving adherence to medication regimens.




Laura Karas, MD, MPH

Latest:

Limited Distribution Networks Stifle Competition in the Generic and Biosimilar Drug Industries

A limited distribution network is a pharmaceutical distribution strategy that some drug companies have capitalized upon to obstruct generic and biosimilar competition.


Aileen M. Soper, BA

Latest:

The National Oncology Working Group (NOW) Initiative: Payer and Provider Collaborations in Oncology Benefits Management

This article highlights the work of the National Oncology Working Group (NOW) Initiative.




Bruce A. Feinberg, DO

Latest:

The Impact of Evolving Treatment Options in Multiple Myeloma, Part 10

Bruce A. Feinberg, DO; Ryan Haumschild, PharmD, MS, MBA; Thomas Ollis, MS, RPh; and Joseph Mikhael, MD, discuss the future treatment landscape for the management of multiple myeloma.


Charles Bane, MD

Latest:

The Oncology Medical Home - Beyond Clinical Pathways

Clinical pathways have been emphasized as a means to deliver efficient, quality care and to ensure better outcomes at lower costs. The Oncology Medical Home takes this to the next, more comprehensive, step of quantifying and improving quality and value in cancer care while lowering overall costs.


Genevieve M. Hale, PharmD, BCPS

Latest:

Building Partnerships Between a College of Pharmacy and ACOs: Development of the ACORN SEED

To promote future partnerships among colleges of pharmacy and accountable care organizations, this article describes several initial challenges to partnership formation, including those related to agenda setting and resource utilization.





Michael Stein, MD

Latest:

Health Insurance Design and Conservative Therapy for Low Back Pain

This study examined the association between health insurance design features and choice of physical therapy or chiropractic care by patients with new-onset low back pain.


C. Daniel Mullins, PhD

Latest:

Pragmatic Clinical Trials: US Payers' Views on Their Value

Payers like key traits of pragmatic clinical trials, but are wary of pharmaceutical companies and plan to carefully scrutinize this new, appealing type of evidence.


Sue Ghiloni, RN, CDE

Latest:

CHAPTER 3. Guideline for Detection and Management of Diabetes in Pregnancy

From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts


Dmitry Khodyakov, PhD

Latest:

Insurers’ Perspectives on MA Value-Based Insurance Design Model

This article describes perspectives of Medicare Advantage (MA) insurers about participating in the CMS value-based insurance design model test launched in 2017.



Richard Snyder, MD

Latest:

Medical Homes and Cost and Utilization Among High-Risk Patients

A longitudinal case-control design was used to evaluate the effects of the patient-centered medical home model on medical costs and utilization among high-risk patients.


Ulrika Winblad, PhD

Latest:

Medicare Advantage Control of Postacute Costs: Perspectives From Stakeholders

This qualitative study examines the methods that Medicare Advantage plans use to control or reduce postacute spending and their associated unintended consequences.


Maria Leiva-Salinas, MD, PhD

Latest:

Managing Inappropriate Requests of Laboratory Tests: From Detection to Monitoring

This study shows automatic, practical, simple, and effective strategies designed in the laboratory, in consensus with requesting clinicians, to improve laboratory test appropriateness.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo